Added to YB: 2024-07-19
Pitch date: 2024-07-12
CERT [bullish]
Certara, Inc.
-66.08%
current return
Author Info
No bio for this author
Company Info
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Market Cap
$745.2M
Pitch Price
$15.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.00
P/E
-48.05
EV/Sales
2.14
Sector
Health Care Technology
Category
growth
TimesSquare U.S. Small Cap Growth Strategy Added On: Certara, Inc.
CERT: Bio simulation software/services for drug discovery. Q1 rev beat, but bookings miss led to -22% selloff. Added on weakness due to improving biotech funding & clinical trial starts. Strong position in growing market with potential upside as sector recovers.
Read full article (1 min)